| 21.94 Data as of May 22 | -0.71 / -3.13%Today’s Change | 14.92 Today|||52-Week Range 24.95 | +17.51% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $764.0M |
Company Description
Quidel Corp. develops, manufactures and markets rapid diagnostic testing solutions. Its solutions are provided under various brands such as QuickVue, QuickVue+, Quidel, MicroVue, FreshCells, D FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, and Thyretain. The company primarily includes applications in infectious diseases, women's health and gastrointestinal diseases. It sells products to physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics and wellness screening centers. Quidel was founded in 1979 and is headquartered in San Diego, CA.
Employees

Shareholders
| Mutual fund holders | 49.84% |
| Other institutional | 36.26% |
| Individual stakeholders | 18.81% |
Top Executives
| Douglas C. Bryant | President, Chief Executive Officer & Director |
| Scot M. McLeod | Senior Vice President-Operations |
| Randall J. Steward, CPA | Chief Financial Officer |
| Timothy Tood Stenzel, MD, PhD | Chief Scientific Officer |
| Mark W. Smits | SVP-North American Commercial Operations |